
|Videos|February 9, 2015
How Will Biosimilars Impact the US?
Raulo Frear, PharmD, general manager of OmedaRx, discusses the ramifications of biosimilars hitting the US market.
Advertisement
Raulo Frear, PharmD, general manager of OmedaRx, discusses the ramifications of biosimilars hitting the US market.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Key Pharmacotherapy Advances in Type 1 and Type 2 Diabetes
2
McKesson ideaShare 2026: Health Mart and Health Mart Atlas’ Role in Supporting Independent Pharmacies in 2026
3
ADA 2026: Lipid Management and Cardiovascular Prevention Updates for People With Diabetes
4
McKesson ideaShare 2026: Why Automation and AI Are Reshaping the Dispensing Experience
5




















































































































